Shields SD, Butt RP, Dib-Hajj SD, Waxman SG. Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis. PLoS ONE. 2015 Mar 06;10(3):e0119067. doi: 10.1371/journal.pone.0119067.